InGel Therapeutics is a startup based in the United States.
InGel Therapeutics is a startup based in the United States.
InGel Therapeutics develops engineered cell therapies using precursor retinal neurons combined with a biomimetic hydrogel platform to treat complex retinal degenerative diseases such as retinitis pigmentosa, dry AMD, and glaucoma.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.